|
Market Closed -
Nasdaq
04:00:00 2026-01-05 pm EST
|
5-day change | 1st Jan Change | ||
| 4.660 USD | -0.21% |
|
-.--% | +3.10% |
| Apr. 15 | Evotec Taps CureVac Executive as COO | MT |
| Jan. 06 | CureVac ends coverage after BioNTech acquisition |  |
| Market Cap | 867M 976M 811M 739M 1.39B 93.97B 1.41B 9.81B 3.8B 47.86B 3.66B 3.58B 154B | P/E 2023 |
-3.23x | P/E 2024 | 4.57x |
|---|---|---|---|---|---|
| Enterprise Value | 424M 477M 397M 361M 680M 45.97B 690M 4.8B 1.86B 23.41B 1.79B 1.75B 75.2B | EV / Sales 2023 |
9.16x | EV / Sales 2024 | 0.55x |
| Free-Float |
-
| Yield 2023 * |
-
| Yield 2024 | - |
Last Transcript: CureVac
| 1 day | -0.21% | ||
| Current year | +3.10% |
| Current year | 4.48 |  | 4.68 |
| 1 year | 4 | | 5.55 |
| 3 years | 2.22 | | 6.44 |
| 5 years | 2.22 | | 50.09 |
| 10 years | 2.22 | | 151.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 2023-03-27 | |
Myriam Mendila
CTO | Chief Tech/Sci/R&D Officer | 60 | - |
Malte Greune
COO | Chief Operating Officer | 61 | 2021-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 76 | 2015-07-31 | |
Mathias Hothum
BRD | Director/Board Member | 58 | 2015-07-31 |
| Director/Board Member | 69 | 2022-06-21 |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 53.76M 60.52M 50.27M 45.81M 86.25M 5.83B 87.43M 608M 235M 2.97B 227M 222M 9.53B | 535M 603M 500M 456M 859M 58.01B 870M 6.05B 2.34B 29.55B 2.26B 2.21B 94.9B |
| Net income | -260M -293M -243M -222M -417M -28.2B -423M -2.94B -1.14B -14.36B -1.1B -1.08B -46.13B | 162M 183M 152M 138M 260M 17.58B 264M 1.83B 710M 8.95B 686M 671M 28.76B |
| Net Debt | -361M -406M -337M -307M -579M -39.09B -587M -4.08B -1.58B -19.91B -1.52B -1.49B -63.95B | -443M -499M -414M -377M -710M -48B -720M -5.01B -1.94B -24.44B -1.87B -1.83B -78.51B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- CVAC Stock
Select your edition
All financial news and data tailored to specific country editions
